Score Breakdown
Offering Ability
60
Cash Runway
85
Float Risk
12
Warrant Exposure
15
Convertible Debt
40
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 45%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.07 below $1 exchange minimum
• Only 6 months cash — financial pressure
💰 Capital Raise
model 35%
• Low cash runway: 6 months remaining
Market Data
Market Cap$462.1K
Shares Outstanding4.62M
Float4.33M
Cash$2.16M
Debt$264.1K
Short InterestN/A
Institutional Holdings
1.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest2.5K
Days to Cover1.0
% of Float0.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-09-30
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual LIPO Dilution Snapshot
Lipella Pharmaceuticals Inc. (LIPO) has a DilutionScore of 51/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 117,750.
- Recent SEC activity tracked for LIPO: xbrl on 2025-09-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: